Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1
- PMID: 7745720
- PMCID: PMC189087
- DOI: 10.1128/JVI.69.6.3712-3720.1995
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1
Abstract
Human immunodeficiency virus type 1 (HIV-1) isolates derived directly from clinical samples are usually unable to grow in cytokine-independent continuous cell lines, thus hindering the study of their biological features and their sensitivity to humoral and cellular protective immunity. To overcome these limitations, we have derived from the Hut78 T-cell line a CD4+ clone (PM1) characterized by a unique susceptibility to a wide range of HIV-1 isolates, including primary and biologically pure macrophage (M phi)-tropic isolates (e.g., HIV-1BaL), which are unable to infect other human T- or promonocytic cell lines. Both primary and M phi-tropic HIV-1 establish persistent infection in PM1, with sustained levels of virus replication for prolonged periods. Experiments with chimeric viruses containing envelope fragments of HIV-1BAL inserted into the genetic framework of HXB2, a molecular clone derived from the cell-line-tropic isolate HIV-1IIIB, showed the third hypervariable domain (V3) of gp120 to be a critical determinant of the cell line tropism of HIV-1. Nevertheless, the V3 loop of HIV-1BaL was not sufficient to confer on the chimeras a bona fide M phi tropism. The biological characteristics of HIV-1BaL and of a primary isolate (HIV-1(573)) were investigated by using the PM1 clone. Infection of PM1 by HIV-1BaL was critically dependent on the CD4 receptor, as shown by competition experiments with an anti-CD4 monoclonal antibody (OKT4a) or with soluble CD4. However, the amount of soluble CD4 required for inhibition of HIV-1BaL was approximately 100-fold higher than for HIV-1IIIB, suggesting that the affinity of HIV-1BaL for CD4 is significantly lower. Infection of PM1 with either HIV-1BaL or HIV-1(573) failed to induce downregulation of surface CD4 expression and syncytium formation. Analogous results were obtained with a chimeric virus (HXB2[BaL PvuII-BamHI]) encompassing a large portion of gp120 and gp41 of HIV-1BaL, indicating that the env genes contain critical determinants for CD4 downregulation and syncytium formation. Consistent with the lack of CD4 downregulation, persistent infection of PM1 by HIV-1BaL or HIV-1(573) failed to interfere with HIV-1IIIB superinfection, as revealed by the expression of a type-specific V3 loop epitope (M77) and by the induction of extensive syncytium formation. This lack of interference suggests that a direct viral interaction may occur in vivo between biologically diverse HIV-1 strains.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Phenotypic Correlates of HIV-1 Macrophage Tropism.J Virol. 2015 Nov;89(22):11294-311. doi: 10.1128/JVI.00946-15. Epub 2015 Sep 2. J Virol. 2015. PMID: 26339058 Free PMC article.
-
Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.J Virol. 1994 Jul;68(7):4409-19. doi: 10.1128/JVI.68.7.4409-4419.1994. J Virol. 1994. PMID: 7515973 Free PMC article.
-
HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.J Virol. 2018 Jan 2;92(2):e00841-17. doi: 10.1128/JVI.00841-17. Print 2018 Jan 15. J Virol. 2018. PMID: 29118121 Free PMC article.
-
Viral determinants of HIV-1 macrophage tropism.Viruses. 2011 Nov;3(11):2255-79. doi: 10.3390/v3112255. Epub 2011 Nov 15. Viruses. 2011. PMID: 22163344 Free PMC article. Review.
-
HIV progression to AIDS: bioinformatics approach to determining the mechanism of action.Curr HIV Res. 2013 Jan;11(1):30-42. Curr HIV Res. 2013. PMID: 22998236 Review.
Cited by
-
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.PLoS One. 2013 Apr 22;8(4):e61416. doi: 10.1371/journal.pone.0061416. Print 2013. PLoS One. 2013. PMID: 23630586 Free PMC article.
-
Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir.J Virol. 2012 Mar;86(5):2696-705. doi: 10.1128/JVI.06591-11. Epub 2011 Dec 28. J Virol. 2012. PMID: 22205735 Free PMC article.
-
Upstream AUG codons in the simian immunodeficiency virus SIVmac239 genome regulate Rev and Env protein translation.J Virol. 2012 Nov;86(22):12362-71. doi: 10.1128/JVI.01532-12. Epub 2012 Sep 5. J Virol. 2012. PMID: 22951834 Free PMC article.
-
Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G.Mol Ther Nucleic Acids. 2019 Dec 6;18:1023-1038. doi: 10.1016/j.omtn.2019.10.024. Epub 2019 Oct 31. Mol Ther Nucleic Acids. 2019. PMID: 31778955 Free PMC article.
-
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry.J Virol. 2007 Mar;81(5):2359-71. doi: 10.1128/JVI.02006-06. Epub 2006 Dec 20. J Virol. 2007. PMID: 17182681 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials